Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis

This post hoc analysis of ACQUIRE (NCT00559585) explored the effect of baseline body mass index (BMI) on the pharmacokinetics of and clinical response to subcutaneous (SC) or intravenous (IV) abatacept in patients with rheumatoid arthritis (RA). ACQUIRE was a phase 3b, 6-month, double-blind, double-...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Agostino, Maria-Antonietta, Alten, Rieke, Mysler, Eduardo, Le Bars, Manuela, Ye, June, Murthy, Bindu, Heitzmann, Julia, Vadanici, Radu, Ferraccioli, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681604/
https://www.ncbi.nlm.nih.gov/pubmed/28822046
http://dx.doi.org/10.1007/s10067-017-3788-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681604/
https://www.ncbi.nlm.nih.gov/pubmed/28822046
http://dx.doi.org/10.1007/s10067-017-3788-1

Ejemplares similares